Explore more publications!
Africa News Ledger
Got News to Share?

Africa News Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Ledger.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on December 22, 2025

ValOre Appoints Engineering Company Lycopodium to Advance Pedra Branca PEA Study
December 22, 2025

ValOre Appoints Engineering Company Lycopodium to Advance Pedra Branca PEA Study

Indeterminate GlobeNewswire
Daura Gold Commences Exploration at Latin Metals’ Cerro Bayo Project, Santa Cruz Province, Argentina
December 22, 2025

Daura Gold Commences Exploration at Latin Metals’ Cerro Bayo Project, Santa Cruz Province, Argentina

Indeterminate GlobeNewswire
Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®
December 22, 2025

Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®

Indeterminate GlobeNewswire
Rapid Progress Reported at Golden Pike Gold-Antimony Property under Option from Globex
December 22, 2025

Rapid Progress Reported at Golden Pike Gold-Antimony Property under Option from Globex

Indeterminate GlobeNewswire
Entera Bio Announces New Data Supporting Further Development of a Proprietary First-in-Class Oral, Long-Acting PTH Tablet for Patients with Hypoparathyroidism (EB612 Program)
December 22, 2025

Entera Bio Announces New Data Supporting Further Development of a Proprietary First-in-Class Oral, Long-Acting PTH Tablet for Patients with Hypoparathyroidism (EB612 Program)

Indeterminate GlobeNewswire
Rectify and Boehringer Ingelheim Collaborate to Advance First-in-class Treatments for Chronic Kidney Disease
December 22, 2025

Rectify and Boehringer Ingelheim Collaborate to Advance First-in-class Treatments for Chronic Kidney Disease

Indeterminate GlobeNewswire
Nasus Pharma CEO Issues 2025 Letter to Shareholders
December 22, 2025

Nasus Pharma CEO Issues 2025 Letter to Shareholders

Indeterminate GlobeNewswire
SCYNEXIS Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
December 22, 2025

SCYNEXIS Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement

Indeterminate GlobeNewswire
Entrée Resources Provides Update on Entrée/Oyu Tolgoi Joint Venture License Matters
December 22, 2025

Entrée Resources Provides Update on Entrée/Oyu Tolgoi Joint Venture License Matters

Indeterminate GlobeNewswire
ORYZON Expands Global Patent Protection for Iadademstat with Grant Decision in Japan Covering Combinations with PD-1/PD-L1 Inhibitors
December 22, 2025

ORYZON Expands Global Patent Protection for Iadademstat with Grant Decision in Japan Covering Combinations with PD-1/PD-L1 Inhibitors

Indeterminate GlobeNewswire
Belo Sun Announces Private Placement Financing
December 22, 2025

Belo Sun Announces Private Placement Financing

Indeterminate GlobeNewswire
VR Extends Brokered Private Placement Led by Centurion One Capital, and Continues Planning towards Exploration on its New Boston and Bonita Projects in Nevada in 2026
December 22, 2025

VR Extends Brokered Private Placement Led by Centurion One Capital, and Continues Planning towards Exploration on its New Boston and Bonita Projects in Nevada in 2026

Indeterminate GlobeNewswire
Secura Bio Provides Corporate Update and Highlights Progress in its Phase 3 TERZO Study
December 22, 2025

Secura Bio Provides Corporate Update and Highlights Progress in its Phase 3 TERZO Study

Indeterminate GlobeNewswire
GFG Receives Final Payment from the Sale of its Rattlesnake Hills Gold Project
December 22, 2025

GFG Receives Final Payment from the Sale of its Rattlesnake Hills Gold Project

Indeterminate GlobeNewswire
Abbisko Therapeutics’ CSF-1R Inhibitor Pimicotinib Approved by the China NMPA, Addressing the Treatment Gap for Tenosynovial Giant Cell Tumor
December 22, 2025

Abbisko Therapeutics’ CSF-1R Inhibitor Pimicotinib Approved by the China NMPA, Addressing the Treatment Gap for Tenosynovial Giant Cell Tumor

Indeterminate GlobeNewswire
和誉医药CSF-1R抑制剂贝捷迈®获NMPA批准，填补中国腱鞘巨细胞瘤系统性治疗空白
December 22, 2025

和誉医药CSF-1R抑制剂贝捷迈®获NMPA批准，填补中国腱鞘巨细胞瘤系统性治疗空白

Indeterminate GlobeNewswire
MEXC Partners with ether.fi to Launch the Enhanced Payment Card with Up to 4% Cashback
December 22, 2025

MEXC Partners with ether.fi to Launch the Enhanced Payment Card with Up to 4% Cashback

Indeterminate GlobeNewswire
MEXC Upgrades 0-Fee Spot Trading to Cover All Pairs
December 22, 2025

MEXC Upgrades 0-Fee Spot Trading to Cover All Pairs

Indeterminate GlobeNewswire
Windward Bio Expands Immunology Pipeline With WIN027, a Long-Acting, Clinical-Stage Bispecific Targeting TSLP and IL-13
December 22, 2025

Windward Bio Expands Immunology Pipeline With WIN027, a Long-Acting, Clinical-Stage Bispecific Targeting TSLP and IL-13

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions